◔
Prolotherapy Injection: Difference between revisions
From WikiMSK
m (โโArticles) |
|||
Line 4: | Line 4: | ||
== Articles == | == Articles == | ||
{{PDF|Fullerton2018.pdf| | {{PDF|Fullerton2018.pdf|Prolotherapy for the thoracolumbar fascia - Fullerton 2018}} | ||
==References== | ==References== |
Revision as of 14:21, 16 March 2022
This article is a stub.
See Hauser et al for a free open access systematic review from 2016.[1]The most commonly use agent is dextrose usually in concentrations between 5-20%. Some use tetradecyl (2mL 3% tetradecyl diluted in 50mL vial of prilocaine to make 0.11%) or polidocanol for those with sulfate allergies. Dextrose can be obtained by MPSO, while tetradecyl and polidocanol can be obtained from NZ scientific and medical.
Articles
References
Literature Review
- Reviews from the last 7 years: review articles, free review articles, systematic reviews, meta-analyses, NCBI Bookshelf
- Articles from all years: PubMed search, Google Scholar search.
- TRIP Database: clinical publications about evidence-based medicine.
- Other Wikis: Radiopaedia, Wikipedia Search, Wikipedia I Feel Lucky, Orthobullets,